Relmada Therapeutics, Inc. RLMD Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s compensation and benefits?
- Relmada Therapeutics, Inc. (RLMD) reported compensation and benefits of $956.19K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s compensation and benefits changed year-over-year?
- Relmada Therapeutics, Inc.'s compensation and benefits decreased by 73.2% year-over-year, from $3.57M to $956.19K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s compensation and benefits?
- Over 4 years (2021 to 2025), Relmada Therapeutics, Inc.'s compensation and benefits has grown at a -23.4% compound annual growth rate (CAGR), from $40.49M to $13.91M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.